Triple

T10292310
Position Surface form Disambiguated ID Type / Status
Subject human adenovirus serotype 26 E241391 entity
Predicate encodesInCOVID19Vaccine P14248 FINISHED
Object SARS-CoV-2 spike glycoprotein
The SARS-CoV-2 spike glycoprotein is the viral surface protein that mediates coronavirus entry into human cells and is the primary target of neutralizing antibodies and many COVID-19 vaccines.
E854994 NE FINISHED

How this triple was built (5 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: SARS-CoV-2 spike glycoprotein | Statement: [human adenovirus serotype 26, encodesInCOVID19Vaccine, SARS-CoV-2 spike glycoprotein]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: SARS-CoV-2 spike glycoprotein
Context triple: [human adenovirus serotype 26, encodesInCOVID19Vaccine, SARS-CoV-2 spike glycoprotein]
  • A. SARS-CoV-2
    SARS-CoV-2 is the novel coronavirus responsible for the global outbreak of the respiratory disease COVID-19.
  • B. REGN-COV2
    REGN-COV2 is a monoclonal antibody cocktail designed to prevent and treat COVID-19 by targeting the SARS-CoV-2 virus.
  • C. BNT162b2
    BNT162b2 is an mRNA-based COVID-19 vaccine, co-developed by BioNTech and Pfizer, that became one of the first widely authorized vaccines against SARS-CoV-2.
  • D. Omicron variant
    The Omicron variant is a highly mutated and fast-spreading strain of the SARS-CoV-2 virus that caused major global surges in COVID-19 cases starting in late 2021.
  • E. Omicron
    Omicron is a vowel letter of the Greek alphabet, historically representing a short "o" sound and used today in various scientific and mathematical contexts.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: SARS-CoV-2 spike glycoprotein
Triple: [human adenovirus serotype 26, encodesInCOVID19Vaccine, SARS-CoV-2 spike glycoprotein]
Generated description
The SARS-CoV-2 spike glycoprotein is the viral surface protein that mediates coronavirus entry into human cells and is the primary target of neutralizing antibodies and many COVID-19 vaccines.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: SARS-CoV-2 spike glycoprotein
Target entity description: The SARS-CoV-2 spike glycoprotein is the viral surface protein that mediates coronavirus entry into human cells and is the primary target of neutralizing antibodies and many COVID-19 vaccines.
  • A. SARS-CoV-2
    SARS-CoV-2 is the novel coronavirus responsible for the global outbreak of the respiratory disease COVID-19.
  • B. REGN-COV2
    REGN-COV2 is a monoclonal antibody cocktail designed to prevent and treat COVID-19 by targeting the SARS-CoV-2 virus.
  • C. BNT162b2
    BNT162b2 is an mRNA-based COVID-19 vaccine, co-developed by BioNTech and Pfizer, that became one of the first widely authorized vaccines against SARS-CoV-2.
  • D. Omicron variant
    The Omicron variant is a highly mutated and fast-spreading strain of the SARS-CoV-2 virus that caused major global surges in COVID-19 cases starting in late 2021.
  • E. Omicron
    Omicron is a vowel letter of the Greek alphabet, historically representing a short "o" sound and used today in various scientific and mathematical contexts.
  • F. None of above. chosen
PD Predicate disambiguation gpt-5-mini-2025-08-07
Target predicate: encodesInCOVID19Vaccine
Context triple: [human adenovirus serotype 26, encodesInCOVID19Vaccine, SARS-CoV-2 spike glycoprotein]
  • A. covid19VaccineType
    Indicates the specific type or category of COVID-19 vaccine associated with an entity.
  • B. encodes chosen
    Indicates that one entity contains or represents the information, instructions, or structure of another in a coded or symbolic form.
  • C. vaccineUsed
    Indicates that a particular vaccine has been administered or applied in a given medical or experimental context.
  • D. encodedIn
    Indicates that one entity is represented, stored, or expressed within another entity using a specific encoding or format.
  • E. notEncodedIn
    Indicates that a piece of information, data, or content is explicitly absent from or not represented within a given encoding, format, or medium.
  • F. None of above.

Provenance (6 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d381aaafc08190af475ef58dc16aba completed April 6, 2026, 9:49 a.m.
NER Named-entity recognition batch_69d4d2d35f048190a215493acdf1f718 completed April 7, 2026, 9:48 a.m.
NED1 Entity disambiguation (via context triple) batch_69d71d1465e88190aaa8b295df3f9c8c completed April 9, 2026, 3:29 a.m.
NEDg Description generation batch_69d73180d90481908f1b4768230edd36 completed April 9, 2026, 4:56 a.m.
NED2 Entity disambiguation (via description) batch_69d7326b14988190bff33dc01e690707 completed April 9, 2026, 5 a.m.
PD Predicate disambiguation batch_69d4d1f35e548190be3b4d92d65d2d20 completed April 7, 2026, 9:44 a.m.
Created at: April 6, 2026, 11:42 a.m.